| What's New |
 |
EPA Tolerance Reassessment Decision for streptomycin ( PDF [142 kbs/16 pages]).
An August 16, 2006 Federal Register notice announced the availability of the TRED and final support documents under docket number EPA-HQ-OPP-2005-0493 |
|
EPA Tolerance Reassessment Decision for oxytetracycline ( PDF [138 kbs/15 pages]).
An August 16, 2006 Federal Register notice announced the availability of the TRED and final support documents under docket number EPA-HQ-OPP-2005-0492 |
| What's New Archive |
|
2003 Annual Report (Released June 2004)
Antimicrobial Resistance Interagency Task Force Annual Report on A Public Health Action Plan To Combat Antimicrobial Resistance |
|
Public Meeting, June 2004
An open meeting to receive public comment on the Antimicrobial Resistance Interagency Task Force annual report. The Federal Register Announcement is also available |
|
Grant Announcement:
Applied Research on Antimicrobial Resistance: Estimates of Economic Cost for Antimicrobial Resistant Human Pathogens of Public Health Importance
Letter of Intent Deadline: May 17, 2004
Application Deadline: June 14, 2004 |
|
2002 Annual Report.
Antimicrobial Resistance Interagency Task Force Annual Report on A Public Health Action Plan To Combat Antimicrobial Resistance (Part I: Domestic Issues) |
|
Alliance for the Prudent Use of Antibiotics
ROAR II Project: Request for Proposals: Studies to detect and quantify the transfer of antibiotic resistance elements from non-infecting bacteria to pathogens. Any questions regarding this RFP should be directed to the ROAR Principal Investigator: Proposals are due no later than October 15, 2003.  PDF (108 KB/3 pages) |
|
Methicillin Resistant Staphylococcus aureus (MRSA) Fact Sheet
Addresses frequently asked questions about infections with antibiotic-resistant Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]) among persons who have no apparent contact with the healthcare system |
|
2001 Annual Report.
Antimicrobial Resistance Interagency Task Force Annual Report on A Public Health Action Plan To Combat Antimicrobial Resistance (Part I: Domestic Issues) |
|
FDA announces Public Meeting on Antimicrobial Resistance — October 2, 2002 - "Discussion of the 'Draft Guidance for Industry: Evaluating the Safety of Antimicrobial New Animal Drugs with Regards to Their Microbiological Effects on Bacteria of Human Health Concern'" |
|
FDA Draft Guidance for Industry: Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on Bacteria of Human Health Concern
Word Version (.doc)
PDF Version (.pdf) |
|
Innovative Approaches for Combating Antimicrobial Resistance
The National Institute of Allergy and Infectious Disease (NIAID) solicits exploratory/developmental (R21) and small research grant (R03) applications for novel and innovative research, including high risk and high payoff studies in nontraditional fields to enhance the understanding of the factors affecting the development of resistant pathogens and spread of resistance genes, in order to direct actions to diagnose, control and treat antimicrobial resistance.
Letter of Intent Receipt Date: September 10, 2002 (not required, but helpful to NIH in planning review of applications)
Application deadline Receipt Date: October 10, 2002 |
|
Protecting the Nation's Health in an Era of Globalization: CDC's Global Infectious Disease Strategy
CDC's plan for control and prevention of infectious diseases throughout the world |
|
Campaign to Prevent Antimicrobial Resistance in Healthcare Settings
From the CDC Division of Healthcare Quality Promotion |
|
Campaign for Appropriate Antibiotic Use in the Community
From the CDC Division of Bacterial and Mycotic Diseases |
|
Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)
IMPART is designed to track the spread of antimicrobial-resistant bacteria and improve use of antimicrobial drugs in rural areas of Idaho and Utah. The website includes tools for clinicians and infection control practitioners, including algorithms, fact sheets, and a decision support program that can be downloaded to a personal digital assistant (PDA). |
|
Multi-level Antimicrobial Susceptibility Testing Educational Resources (MASTER)
New site from the NCID Division of Healthcare Quality Promotion (DHQP) and the Public Health Practice Program Office (PHPPO) Division of Laboratory Systems (DLS) about antimicrobial susceptibility testing issues as related to clinical microbiology laboratory practice. |
